Technology area: Biotechnology & Pharmaceuticals
9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
FMC Corporation currently maintains 8 pending office actions focused in the Biotechnology & Pharmaceuticals technology area. These 8 actions are distributed among 8 distinct examiners, meaning that every pending matter is being reviewed by a different official. This complete lack of examiner overlap across the 8 pending actions suggests that the portfolio contains a highly varied set of technical claims within the biotechnology sector.
The prosecution effort is spread across 7 distinct art units, showing that the 8 pending office actions are classified into several different technical categories at the patent office. KOSAR, ANDREW D is the busiest examiner for the portfolio, currently responsible for 1 pending office action. Since every one of the 8 distinct examiners is handling exactly 1 pending action, the workload is evenly distributed across the entire group. This parity across 8 distinct examiners and 7 distinct art units indicates a broad prosecution front where each of the 8 pending office actions likely requires a unique tactical approach.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (56%) |
| §112 only | 1 (11%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROSENTHAL, ANDREW S | 1 | 51.9% | +39.0% |
| KOSAR, ANDREW D | 1 | 41.9% | +31.9% |
| COLEMAN, BRENDA LIBBY | 1 | 74.8% | +15.7% |
| HIRT, ERIN E | 1 | 40.6% | +22.9% |
| WERTZ, ASHLEE ELIZABETH | 1 | 52.7% | +35.6% |
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
| PAK, JOHN D | 1 | 52.3% | +37.8% |
| SCHLIENTZ, NATHAN W | 1 | 41.3% | -18.8% |
| KWON, JOHN SEUNGJAI | 1 | 44.9% | +20.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18127373 | SUBSTITUTED TOLYL FUNGICIDES | JANOSKO, CHASITY PAIGE | 42d overdue |
| 18856302 | NOVEL SULFONATE BENZAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | KOSAR, ANDREW D | — |
| 18018323 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | PAK, JOHN D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267619 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | WERTZ, ASHLEE ELIZABETH | 45d overdue |
| 18127373 | SUBSTITUTED TOLYL FUNGICIDES | JANOSKO, CHASITY PAIGE | 42d overdue |
| 18419734 | HERBICIDAL MIXTURE, COMPOSITION AND METHOD | HIRT, ERIN E | 27d |
| 19116533 | COMPOSITIONS INCLUDING ENCAPSULATED BIXLOZONE AND NON ENCAPSULATED BIXLOZONE | ROSENTHAL, ANDREW S | — |
| 18856302 | NOVEL SULFONATE BENZAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | KOSAR, ANDREW D | — |
| 18839283 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | COLEMAN, BRENDA LIBBY | — |
| 18018323 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | PAK, JOHN D | — |
| 17051926 | AQUEOUS CAPSULE SUSPENSION CONCENTRATES CONTAINING A HERBICIDAL SAFENER AND A PESTICIDAL ACTIVE SUBSTANCE | KWON, JOHN SEUNGJAI | — |
| Art Unit | Apps |
|---|---|
| 1613 | 2 |
| 1616 | 2 |
| 1625 | 1 |
| 1624 | 1 |
| 1612 | 1 |
| 1699 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19116533 | COMPOSITIONS INCLUDING ENCAPSULATED BIXLOZONE AND NON ENCAPSULATED BIXLOZONE | ROSENTHAL, ANDREW S | 1613 | §103 | Non-Final OA | — | Pending | Mar 28, 2025 |
| 18856302 | NOVEL SULFONATE BENZAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | KOSAR, ANDREW D | 1625 | §102§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18839283 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | COLEMAN, BRENDA LIBBY | 1624 | §112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18419734 | HERBICIDAL MIXTURE, COMPOSITION AND METHOD | HIRT, ERIN E | 1616 | §103 | Non-Final OA | 27d | Pending | Jan 23, 2024 |
| 18267619 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | WERTZ, ASHLEE ELIZABETH | 1612 | §103DP | Final Rejection | 45d overdue | Pending | Jun 15, 2023 |
| 18127373 | SUBSTITUTED TOLYL FUNGICIDES | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | 42d overdue | Pending | Mar 28, 2023 |
| 18018323 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | PAK, JOHN D | 1699 | §102§103§112 | Final Rejection | — | Pending | Jan 27, 2023 |
| 18159265 | PYRROLIDINONES HERBICIDES | SCHLIENTZ, NATHAN W | 1616 | §103 | Final Rejection | — | Pending | Jan 25, 2023 |
| 17051926 | AQUEOUS CAPSULE SUSPENSION CONCENTRATES CONTAINING A HERBICIDAL SAFENER AND A PESTICIDAL ACTIVE SUBSTANCE | KWON, JOHN SEUNGJAI | 1615 | §103 | Non-Final OA | — | Pending | Oct 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFMC Corporation has 9 pending office actions as of October 2026, spread across 7 art units and 9 examiners.
Andrew S Rosenthal has the most, with 1 of FMC Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
